Cell-mediated immunity is a crucial arm of the immune system that involves the activation and participation of immune cells, particularly T lymphocytes (T cells). This branch of immunity is essential for recognizing and eliminating intracellular pathogens, such as viruses and certain bacteria, as well as abnormal or cancerous cells. Cell-mediated immunity begins with the presentation of antigens by specialized cells, like macrophages and dendritic cells, to T cells. This interaction activates T cells, leading to the differentiation of cytotoxic T cells that directly target and destroy infected or abnormal cells. Helper T cells play a central role in coordinating immune responses by activating other immune cells. Cytokines, signaling molecules released by immune cells, modulate cell-mediated responses and contribute to the regulation of inflammation. The major histocompatibility complex (MHC) plays a key role in presenting antigens to T cells, facilitating the recognition of infected or abnormal cells. Cell-mediated immunity is critical for defense against intracellular pathogens and the surveillance of transformed cells. It also plays a role in autoimmune responses and transplant rejection. Understanding the intricacies of cell-mediated immunity is essential for developing vaccines, immunotherapies, and strategies to manage immune-related disorders.
Title : A universal AI design framework and brokerage platform for democratised manufacturing of mRNA therapeutics
Duccio Medini, BioForge, United States
Title : Personalized and Precision Medicine (PPM) via biodesign-driven translational applications and upgraded business modeling to secure the human biosafety: The next-step vaccinomics of the future
Sergey V Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Development of VSV-vector based vaccine against H5N1 avian influenza by targeting both H5N1 hemagglutinin and matrix protein 2
Zhujun Ao, University of Manitoba, Canada
Title : A novel responsive microneedle platform for reliable drug and vaccine delivery
Huanhuan Li, Queen’s University Belfast, United Kingdom
Title : Emerging nanovaccine strategies for enhanced immune targeting and vaccine performance
Aysel Sadayli, V.Y. Axundov Scientific-Research Institute of Medical Prophylaxis, Azerbaijan
Title : The promise of nanotechnology in Personalized & Precision Medicine: Nano-driven precision vaccinomics of the future
Sergey V Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Reaching zero-dose children through adaptive immunization strategies in security-compromised areas of Zamfara State, Nigeria
Attahir Abubakar, Ahmadu Bello University, Nigeria
Title : Comparative efficacy of different H9N2 avian influenza virus inactivated vaccines using some commercially available adjuvants for superior control in broilers
Ayman H M El Deeb, Cairo University, Egypt
Title : Structure-based design and development of next-generation Respiratory Syncytial Virus (RSV) vaccine
Lei Chen, Yikang Biotech Suzhou Co., Ltd, China
Title : Unmasking urban immunization inequities: A cross-sectional LQAS analysis of zero-dose drivers in slum and non-slum settings of Uttar Pradesh, India
Ashish Kumar Maurya, John Snow India, India